Literature DB >> 22959961

Reprogramming aging and progeria.

José M P Freije1, Carlos López-Otín.   

Abstract

The aging rate of an organism depends on the ratio of tissue degeneration to tissue repair. As a consequence, molecular alterations that tip this balance toward degeneration cause accelerated aging. Conversely, interventions can be pursued to reduce tissue degeneration or to increase tissue repair with the aim of delaying the onset of age-associated manifestations. Recent studies on the biology of stem cells in aging have revealed the influence of systemic factors on their functionality and demonstrated the feasibility of reprogramming aged and progeroid cells. These results illustrate the reversibility of some aspects of the aging process and encourage the search for new anti-aging and anti-progeria interventions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2012        PMID: 22959961     DOI: 10.1016/j.ceb.2012.08.009

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  19 in total

1.  NF-κB activation impairs somatic cell reprogramming in ageing.

Authors:  Clara Soria-Valles; Fernando G Osorio; Ana Gutiérrez-Fernández; Alejandro De Los Angeles; Clara Bueno; Pablo Menéndez; José I Martín-Subero; George Q Daley; José M P Freije; Carlos López-Otín
Journal:  Nat Cell Biol       Date:  2015-07-27       Impact factor: 28.824

Review 2.  Proceedings: consideration of genetics in the design of induced pluripotent stem cell-based models of complex disease.

Authors:  Uta Grieshammer; Kelly A Shepard
Journal:  Stem Cells Transl Med       Date:  2014-11       Impact factor: 6.940

Review 3.  Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk.

Authors:  Sreedevi Raman; Nicholas Brookhouser; David A Brafman
Journal:  Neurobiol Dis       Date:  2020-02-05       Impact factor: 5.996

4.  Human iPSC-based modeling of late-onset disease via progerin-induced aging.

Authors:  Justine D Miller; Yosif M Ganat; Sarah Kishinevsky; Robert L Bowman; Becky Liu; Edmund Y Tu; Pankaj K Mandal; Elsa Vera; Jae-won Shim; Sonja Kriks; Tony Taldone; Noemi Fusaki; Mark J Tomishima; Dimitri Krainc; Teresa A Milner; Derrick J Rossi; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2013-12-05       Impact factor: 24.633

5.  Nuclear lamina defects cause ATM-dependent NF-κB activation and link accelerated aging to a systemic inflammatory response.

Authors:  Fernando G Osorio; Clea Bárcena; Clara Soria-Valles; Andrew J Ramsay; Félix de Carlos; Juan Cobo; Antonio Fueyo; José M P Freije; Carlos López-Otín
Journal:  Genes Dev       Date:  2012-09-26       Impact factor: 11.361

Review 6.  Back and forth in time: Directing age in iPSC-derived lineages.

Authors:  Daniela Cornacchia; Lorenz Studer
Journal:  Brain Res       Date:  2015-11-17       Impact factor: 3.252

7.  A novel family of soluble minimal scaffolds provides structural insight into the catalytic domains of integral membrane metallopeptidases.

Authors:  Mar López-Pelegrín; Núria Cerdà-Costa; Francisco Martínez-Jiménez; Anna Cintas-Pedrola; Albert Canals; Juan R Peinado; Marc A Marti-Renom; Carlos López-Otín; Joan L Arolas; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2013-06-03       Impact factor: 5.157

Review 8.  The hallmarks of aging.

Authors:  Carlos López-Otín; Maria A Blasco; Linda Partridge; Manuel Serrano; Guido Kroemer
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

Review 9.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

Review 10.  NF-kB in premature aging.

Authors:  Fernando G Osorio; Carlos López-Otín; José M P Freije
Journal:  Aging (Albany NY)       Date:  2012-11       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.